<DOC>
	<DOCNO>NCT00930943</DOCNO>
	<brief_summary>The purpose study determine whether extended-release oxymorphone hydrochloride take orally high-fat meal , generate approximately 50 % high Cmax , impact cognitive functioning , use Cambridge Neuropsychological Test Automated Battery ( CANTAB ) test , great extent take condition fast .</brief_summary>
	<brief_title>Effect Extended-release Oxymorphone Taking With Without Food Cognitive Functioning</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Oxymorphone</mesh_term>
	<criteria>1 . Man woman , 1865 year age , inclusive 2 . Able provide inform consent comply study procedures 3 . Women childbearing potential negative urine pregnancy test screen adequate contraception 4 . Chronic , nonmalignant , painful condition , treat longacting opioid ( methadone , OxyContin® , MS Contin® , Kadian® , Avinza® , Fentanyl® , Opana® ER ) 5 . Opioid treatment least 3 month prior screen minimum dose 90 mg morphine equivalent per day 50 mcg fentanyl transdermal patch 6 . Dose opioid treatment stable least 1 week prior screen expect stable screen end second test 7 . Weight screen 100300 pound , inclusive 1 . Pregnant breastfeed 2 . Gastrointestinal disorder S/P gastrointestinal surgery impact absorption study medication ( delay gastric empty , partial complete gastrectomy ) 3 . Alcohol substance abuse within 2 year screen 4 . Consumption alcohol within 24 hour screen test visit 5 . Consumption xanthinecontaining beverage ( coffee , tea , coke ) morning screen test visit 6 . Impaired kidney liver function ( transaminase level 3 time elevate ; estimate creatinine clearance le 50 mL/min ) 7 . Epworth sleepiness scale ( ESS ) score 16 high screening 8 . Medically concern hypertension ( ≥ 160/100 ) unstable cardiovascular illness 9 . Any clinically significant illness would interfere study participation put subject risk 10 . Exposure investigational medication within 30 day screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>opioid tolerant</keyword>
	<keyword>chronic pain</keyword>
</DOC>